Development of glutathione-coated quantum dots enhances cell viability in cancer, suggesting novel imaging applications.
The present paper presents the development and characterization of glutathione-coated CdS/ZnS core-shell quantum dots (QDs) for biocompatible cellular imaging and targeting. CdS/ZnS quantum dots were produced using a one-pot high-temperature technique and made water-soluble through ligand exchange with DL-cysteine. Glutathione (GSH) was coupled by EDC/NHS chemistry to enhance stability and biocompatibility, resulting in quantum dots (QDs) with a hydrodynamic diameter of approximately 20 nm, robust blue fluorescence emission at 455 nm, and a quantum yield of 39%. FTIR validated the effective alteration of the GSH surface. MTT studies on MCF-7 and HeLa cells revealed robust cell viability (>90%) at doses up to 10 μg/mL, signifying little cytotoxicity. Confocal imaging demonstrated effective cellular absorption, whereas antibody (EpCAM) conjugation facilitated target labeling and flow cytometric sorting of circulating tumor cells. The GSH-coated quantum dots provide a durable, low-toxicity substitute for conventional fluorophores in cellular imaging and cancer cell identification.
No takes yet. Share an insight, caveat, or question.
Siripelly et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: